We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Emergent to Help Manufacture Humanigen’s COVID-19 Antibody Candidate
Emergent to Help Manufacture Humanigen’s COVID-19 Antibody Candidate
Emergent Biosolutions has entered into an agreement to manufacture Humanigen’s lenzilumab, a potential treatment for COVID-19, ahead of an emergency use filing expected early this year.